The Royal Devon & Exeter NHS Foundation Trust provides high-quality integrated health and care services in Exeter and across Eastern and Mid-Devon to roughly 450,000 people.
One of the first NHS Foundation Trusts nationally in 2004, and with a history dating back over 250 years, they are directly accountable to and work with local people and communities. The RD&E has earned a national and international reputation for the provision of high-quality healthcare, innovation, research and education.
Due to an increase in demand for services, the Royal Devon and Exeter Hospital required extra clinical capacity to increase patient access to transthoracic echocardiography services. Another contributing factor to the challenge was the historical nationwide shortage of suitably qualified Cardiac Physiologists to support the vacancies that the Trust required to be filled.
Xyla was approached by the Trust in mid-2019 with a request for additional clinical capacity to increase the department’s ability to provide transthoracic echocardiography services for an increasing number of monthly patient referrals. Xyla was initially contracted to supply echocardiography services to a volume of 1,210 TTE scans during the first 22-week period, with a 26-week extension period to a minimum capacity of 600 TTE scans.
Due to a large increase in patient referrals, and the successful supply of TTE capacity in the initial term of the contract, the Trust requested a new agreement commencing early May 2020 for the capacity provided by Xyla to increase to 160 TTE scans per week for an initial 35-week period, with a further capacity period to be agreed beyond this. The increase in capacity here was represented by the provision of three full-time Physiologists, compared to one full-time Physiologist in our first contract with the Trust. Through this period, Xyla was able to provide the capacity to support:
The capacity provided was agreed to continue to the same levels for the remainder of the contract, through April 2021, where Xyla was able to provide a further:
Through April 2021, and due to the successful implementation of a long-term, high-volume echocardiography solution, Xyla was invited to re-contract with the Trust to retain our partnership for a further 12-month period. This new requirement was agreed upon at a level of 144 TTE scans per week for an initial 26-week period until the end of October 2021 to a volume of 3744 patients, with a further 26-week capacity to be agreed upon during our Service Review meetings. Through the course of the current agreement, Xyla has provided the following:
Xyla is very proud of our achievements throughout our partnership with the Royal Devon and Exeter NHS Foundation Trust and the work that has been undertaken by our dedicated team of staff. Through an extremely challenging two-year period we have been able to ensure continuous service to the Trust and, further, have been able to increase the overall efficiency with regard to the percentage of clinics filled per week by our on-site team.
During the course of our partnership with the Trust – now totalling in excess of two years, Xyla has been able to ensure coverage for a total of:
Xyla understands that we provide a real benefit to the Trust through the work we continue to do and look forward to our continuing partnership through the remainder of our current agreement and future work together.
We help people to avoid hospital or accelerate them safely through it. Get in touch to find out how our bespoke community solutions can support you.
Have any questions about our services? Whether you’re wondering about how we can help your health goals, or assist your healthcare organisation, we’d love to hear from you.
Get in touchXyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)